High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.
Descripción del Articulo
Objective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sa...
Autores: | , , , , , , , , , , , |
---|---|
Formato: | artículo |
Fecha de Publicación: | 2024 |
Institución: | Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
Repositorio: | Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
Lenguaje: | español |
OAI Identifier: | oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2287 |
Enlace del recurso: | https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287 |
Nivel de acceso: | acceso abierto |
Materia: | covid-19 seroprevalence Tumbes SARS-CoV-2 COVID-19 Peru |
id |
REVCMH_bcd67d2d29bf598e9c6527dcd0e2a0b7 |
---|---|
oai_identifier_str |
oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/2287 |
network_acronym_str |
REVCMH |
network_name_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
repository_id_str |
|
dc.title.none.fl_str_mv |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. Alta seroprevalencia tras la segunda oleada de infección respiratoria por SARS-COV2 en un pequeño asentamiento de la costa norte de Perú. |
title |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
spellingShingle |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. Toledo, Angie K. covid-19 seroprevalence Tumbes SARS-CoV-2 COVID-19 SARS-CoV-2 Peru seroprevalence |
title_short |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
title_full |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
title_fullStr |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
title_full_unstemmed |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
title_sort |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru. |
dc.creator.none.fl_str_mv |
Toledo, Angie K. León-Jimenez, Franco Cavalcanti, Sofia Vilchez-Barreto, Percy Reto, Narcisa Vega, Jessica Bolivar, Lucia M Rhor, Eva M. Ypanaque, Jhon Silva-Marchan, Henry Moyano, Luz M. Neuroepidemiology and Science of Life Working Group (NESL) |
author |
Toledo, Angie K. |
author_facet |
Toledo, Angie K. León-Jimenez, Franco Cavalcanti, Sofia Vilchez-Barreto, Percy Reto, Narcisa Vega, Jessica Bolivar, Lucia M Rhor, Eva M. Ypanaque, Jhon Silva-Marchan, Henry Moyano, Luz M. Neuroepidemiology and Science of Life Working Group (NESL) |
author_role |
author |
author2 |
León-Jimenez, Franco Cavalcanti, Sofia Vilchez-Barreto, Percy Reto, Narcisa Vega, Jessica Bolivar, Lucia M Rhor, Eva M. Ypanaque, Jhon Silva-Marchan, Henry Moyano, Luz M. Neuroepidemiology and Science of Life Working Group (NESL) |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
covid-19 seroprevalence Tumbes SARS-CoV-2 COVID-19 SARS-CoV-2 Peru seroprevalence |
topic |
covid-19 seroprevalence Tumbes SARS-CoV-2 COVID-19 SARS-CoV-2 Peru seroprevalence |
description |
Objective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sampled individuals over 2 years old from one to every four households. We collected finger-prick blood samples and conducted symptom surveys. Results: The adjusted seroprevalence after the second wave increased by twofold (50.15%, 95% CI[45.92–54.40]), compared with the first wave (24.82 %, 95%CI [22.49–27.25]). Females maintained a higher seroprevalence (53.89; 95% CI[48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compared to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave. Conclusions: The seroprevalence of COVID-19 increased by twofold compared to the initial wave in Tumbes region. Infrastructure constraints, restricted human resources, and supply limitations in healthcare facilities made the Peruvian health system collapse. The epidemiological surveillance network should incorporate mHealth tools for real-time notifiable disease information. Working alongside the community will let us improve interventions for preventing or controlling new pandemics. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-04-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287 10.35434/rcmhnaaa.2024.171.2287 |
url |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287 |
identifier_str_mv |
10.35434/rcmhnaaa.2024.171.2287 |
dc.language.none.fl_str_mv |
spa |
language |
spa |
dc.relation.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287/914 |
dc.rights.none.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
dc.source.none.fl_str_mv |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 1 (2024): Early Publication; e2287 Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 1 (2024): Rev. Cuerpo Med. HNAAA, Enero - Marzo; e2287 2227-4731 2225-5109 10.35434/rcmhnaaa.2024.171 reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instacron:HNAAA |
instname_str |
Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
instacron_str |
HNAAA |
institution |
HNAAA |
reponame_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
collection |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1842629794740568064 |
spelling |
High seroprevalence after the second wave of SARS-COV2 respiratory infection in a small settlement on the northern coastal of Peru.Alta seroprevalencia tras la segunda oleada de infección respiratoria por SARS-COV2 en un pequeño asentamiento de la costa norte de Perú.Toledo, Angie K. León-Jimenez, Franco Cavalcanti, Sofia Vilchez-Barreto, Percy Reto, Narcisa Vega, Jessica Bolivar, Lucia M Rhor, Eva M. Ypanaque, Jhon Silva-Marchan, Henry Moyano, Luz M. Neuroepidemiology and Science of Life Working Group (NESL)covid-19seroprevalenceTumbesSARS-CoV-2COVID-19SARS-CoV-2PeruseroprevalenceObjective: a) to assess the seroprevalence of SARS-CoV-2 at the end of the second wave; b) to determine the distribution by age group and health determinants associated with seropositivity. Material and Methodology: A study performed in a Tumbes' settlement between December 2021–January 2022 sampled individuals over 2 years old from one to every four households. We collected finger-prick blood samples and conducted symptom surveys. Results: The adjusted seroprevalence after the second wave increased by twofold (50.15%, 95% CI[45.92–54.40]), compared with the first wave (24.82 %, 95%CI [22.49–27.25]). Females maintained a higher seroprevalence (53.89; 95% CI[48.48-59.23]) vs. 45.49; 95% CI [38.98-52.12], p=0.042) compared to males. Those under 18 years of age had the highest IgG seropositivity: the 12–17 age group during the second wave (85.14%) and the 2–11 age group (25.25%) during the first wave. Nasal congestion and cough were symptoms associated with seropositivity, unlike the first wave. Conclusions: The seroprevalence of COVID-19 increased by twofold compared to the initial wave in Tumbes region. Infrastructure constraints, restricted human resources, and supply limitations in healthcare facilities made the Peruvian health system collapse. The epidemiological surveillance network should incorporate mHealth tools for real-time notifiable disease information. Working alongside the community will let us improve interventions for preventing or controlling new pandemics.Objetivo: a) evaluar la seroprevalencia de SARS-CoV-2 al final de la segunda ola; b) determinar su distribución por grupos de edad y los determinantes de salud asociados a la seropositividad. Materiales y Método: Un estudio realizado en un asentamiento humano de Tumbes entre diciembre de 2021 y enero de 2022 muestreó individuos mayores de 2 años en uno de cada cuatro hogares. Se tomó muestras de sangre por punción-digital y se realizó encuestas sintomáticas. Resultados: La seroprevalencia ajustada tras la segunda ola se duplicó (50.15%, IC 95% [45,92-54,40]), comparado con la primera ola (24.82%, IC 95% [22,49-27,25]). Las mujeres mantuvieron una mayor seroprevalencia (53.89; IC 95% [48,48-59,23] vs. 45.49; IC 95% [38,98-52,12], p = 0,042) comparado con los hombres. Los menores de 18 años presentaron mayor seropositividad IgG: el grupo de 12-17 años durante la segunda ola (85,14%) y el grupo de 2-11 años (25,25%) durante la primera ola. Congestión nasal y tos estuvieron asociados a la seropositividad, a diferencia de la primera oleada. Conclusiones: La seroprevalencia de COVID-19 se duplicó en comparado con la primera ola en Tumbes. Las limitaciones de infraestructura, los recursos humanos restringidos y las limitaciones de abastecimiento en los establecimientos de salud hicieron colapsar el sistema de salud peruano. La red de vigilancia epidemiológica debería incorporar herramientas de mhealth para obtener información en tiempo real sobre las enfermedades. de declaración obligatoria. Trabajar junto a la comunidad nos permitirá mejorar las intervenciones para prevenir o controlar nuevas pandemias.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2024-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/228710.35434/rcmhnaaa.2024.171.2287Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 No. 1 (2024): Early Publication; e2287Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 17 Núm. 1 (2024): Rev. Cuerpo Med. HNAAA, Enero - Marzo; e22872227-47312225-510910.35434/rcmhnaaa.2024.171reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/2287/914Derechos de autor 2024 Angie K. Toledo, Franco León-Jimenez, Sofia Cavalcanti, Percy Vilchez-Barreto, Narcisa Reto, Jessica Vega, Lucia M Bolivar, Matilde Rhor, Jhon Ypanaque, Henry Silva, Luz M. Moyano, Neuroepidemiology and Science of Life Working Group (NESL)https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/22872025-05-14T10:42:36Z |
score |
12.660197 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).